首页> 外国专利> Combined use of clinical risk factors and molecular markers for thrombosis for clinical decision support

Combined use of clinical risk factors and molecular markers for thrombosis for clinical decision support

机译:结合使用临床危险因素和分子标记物进行血栓形成以提供临床决策支持

摘要

The present invention relates to an apparatus and method for clinical decision support that identifies patients at high risk of thrombosis based on a combination of clinical risk factors and molecular markers such as protein concentration. These clinical risk factors and molecular markers are combined in a machine learning based algorithm that returns an output value for the estimated risk of future thrombotic events.
机译:本发明涉及用于临床决策支持的设备和方法,其基于临床风险因素和诸如蛋白质浓度的分子标记的组合来识别处于血栓形成高风险的患者。将这些临床风险因素和分子标记结合在基于机器学习的算法中,该算法返回输出值,以估算未来血栓事件的风险。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号